In a new webinar, industry experts explain how innovative technology is reshaping healthcare delivery, enabling proactive interventions that improve patient outcomes, relieve NHS pressures, and pave ...

Sanofi has announced that its two combination vaccine candidates have received fast track status from the US FDA.

The push to replace Albert Bourla as Pfizer’s CEO drew attention from the pharma industry but was soon derailed by several events.

When a room of physicians at ASH 2024 was asked whether they had prescribed a gene therapy in a commercial context, only a handful said yes.

Updated figures from the WHO show that more than one in five adults aged between 15 and 49 globally have the infection.

Er-Kim has extended its exclusive agreement with Ascendis Pharma for endocrinology treatments across multiple countries in Eurasia.

Relation has announced two strategic collaborations with GSK, focusing on new therapeutics for fibrotic and osteoarthritis.

Missing and incomplete data can cause headaches for clinical trial operators; new innovations are providing an antidote.

If accepted, Vifor Pharma's £23m offer will "claw back" money for the NHS and close the CMA's first-ever disparagement case.

Appropriately planning and conducting early phase clinical trials is critical to setting the stage for successful pivotal studies.

Lilly’s investment and the UK government’s strategic support for life sciences and healthcare represent a pivotal moment for the industry.

Seres Therapeutics has received US FDA breakthrough therapy designation for its SER-155, aimed at decreasing BSIs.